Results 61 to 70 of about 4,253 (175)

Transplantation of bone marrow mononuclear cells decreases seizure incidence, mitigates neuronal loss and modulates pro-inflammatory cytokine production in epileptic rats

Neurobiology of Disease, 2012
Approximately 30% of patients with mesial temporal lobe epilepsy do not respond to treatment with antiepileptic drugs. We have previously shown that transplantation of mononuclear bone marrow cells (BMC) has an anticonvulsant effect in acute epilepsy ...
Zaquer S.M. Costa-Ferro, Bruno S.F. Souza, Marcos M.T. Leal, Carla Martins Kaneto, Carine Machado Azevedo, Igor Campos da Silva, Milena B.P. Soares, Ricardo Ribeiro-dos-Santos, Jaderson C. DaCosta   +8 more
doaj   +1 more source

Biohybrid Vascular Graft Made of Textile‐Reinforced Elastin‐Like Recombinamers and Its Preservation via Drying Processes

Advanced Healthcare Materials, Volume 14, Issue 15, 10 June, 2025.
Clinical translation of biohybrid medical implants requires the previous implementation of drying schemes that can facilitate their sterilization and storage. This study addresses that critical aspect and elucidates the impact of drying on biohybrid vascular grafts, highlighting the need for implant‐specific drying strategies to ensure safety ...
Dominic Pascal Andre, Stephan Ruetten, José Carlos Rodríguez‐Cabello, Stefan Jockenhoevel, Thomas Schmitz‐Rode, Alicia Fernández‐Colino   +5 more
wiley   +1 more source

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VI: Accreditation process. [PDF]

Hematol Transfus Cell Ther, 2021
De Santis GC, Ubiali EMA, Zanelli APRD, Mendrone Junior A, Feitoza A, Kutner JM, Orellana MD, Rizzo SRCP, Covas DT, Langhi Junior DM.   +9 more
europepmc   +1 more source

Terapia Celular con Células Madre

, 2009
Terapia Celular con Células Madre. Colegio Nacional de Médicos Militares 2009; 1, 24-25 En el ámbito de la nueva medicina regenerativa y antienvejecimiento, la terapia celular emplea células madre con el propósito de restaurar lo perdido o dañado en las células envejecidas, así como también en los tejidos enfermos del organismo, utilizando innovadoras
openaire   +1 more source

Terapias celulares para a falência ovariana precoce

Brazilian Journal of Health Review
A falência ovariana precoce (FOP) é uma condição que compromete a fertilidade e a saúde hormonal das mulheres antes dos 40 anos, causando sintomas físicos e emocionais, como infertilidade, osteoporose, depressão e ansiedade. As terapias celulares têm surgido como uma abordagem promissora para restaurar a função ovariana e melhorar a fertilidade.
Andrea Correia Nóbrega de Sá, Emmanuel Marconi Costa Holanda, Enrico Santos de Rezende, José Antônio Santiago Silveira Polaro Araújo, Lívia Eliane Batista Medeiros de Brito, Maria Allice Soares Guimarães, Maria Zelaide Massa Soares de Oliveira Santiago Silveira, Sophia Helenuhyth Souza Silva   +7 more
openaire   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +2 more sources

New methodologies for old problems: tridimensional gastrointestinal organoids and guts-on-a-chip

Journal of Coloproctology, 2018
Objectives: The present review intended to present a critical overview of the methodological and experimental advances concerning tridimensional cell culture models within the scope of gastrointestinal research. Methods: A literature review was performed
Marna Eliana Sakalem, João Tadeu Ribeiro-Paes   +1 more
doaj   +1 more source

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. V: Manufacture and quality control. [PDF]

Hematol Transfus Cell Ther, 2021
De Santis GC, Langhi Junior DM, Feitoza A, Mendrone Junior A, Kutner JM, Covas DT, Couto SCF, Guerino-Cunha RL, Orellana MD, Rizzo SRCP.   +9 more
europepmc   +1 more source

Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2022. Part I. [PDF]

Hematol Transfus Cell Ther, 2022
Maiolino A, Crusoé EQ, Martinez GA, Braga WMT, de Farias DLC, Bittencourt RI, Neto JVP, Ribeiro GN, Bernardo WM, Tristão L, Magalhaes RJP, Hungria VTM.   +11 more
europepmc   +1 more source

Associação Brasileira de Hematologia, Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Review article: Cell therapy in solid tumors. [PDF]

Hematol Transfus Cell Ther, 2021
Nardo M, Motta TC, Colli LM, Avanzi MP.
europepmc   +1 more source